This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
EMD Millipore
other brands :
Oncogene Research Products, Calbiochem, Novagen, Merck, Upstate Biotechnology, Chemicon, LINCO, Novabiochem, Guava
product type :
antibody
product name :
phospho-Src (Tyr416) Antibody, clone 9A6
catalog :
05-677
quantity :
100 μg
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
antigen modification :
phosphorylated
clone name :
9A6

The same clone is also sold as:
reactivity :
human
application :
western blot, immunoprecipitation
citations: 15
Published Application/Species/Sample/DilutionReference
  • western blot; human; loading ...
Waters A, Stewart J, Atigadda V, Mroczek Musulman E, Muccio D, Grubbs C, et al. Preclinical Evaluation of UAB30 in Pediatric Renal and Hepatic Malignancies. Mol Cancer Ther. 2016;15:911-21 pubmed publisher
  • western blot; human; fig 7
Yen Y, Hsiao J, Jiang S, Chang J, Wang S, Shen Y, et al. Insulin-like growth factor-independent insulin-like growth factor binding protein 3 promotes cell migration and lymph node metastasis of oral squamous cell carcinoma cells by requirement of integrin β1. Oncotarget. 2015;6:41837-55 pubmed publisher
  • western blot; human; tbl s3
Cheng H, Liang Y, Kuo Y, Chuu C, Lin C, Lee M, et al. Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data. Cell Death Dis. 2015;6:e1753 pubmed publisher
  • western blot; human; loading ...; fig s1
Megison M, Gillory L, Stewart J, Nabers H, Mrozcek Musulman E, Beierle E. FAK inhibition abrogates the malignant phenotype in aggressive pediatric renal tumors. Mol Cancer Res. 2014;12:514-26 pubmed publisher
Kamekura R, Kolegraff K, Nava P, Hilgarth R, Feng M, Parkos C, et al. Loss of the desmosomal cadherin desmoglein-2 suppresses colon cancer cell proliferation through EGFR signaling. Oncogene. 2014;33:4531-6 pubmed publisher
Miekus K, Lukasiewicz E, Jarocha D, Sekula M, Drabik G, Majka M. The decreased metastatic potential of rhabdomyosarcoma cells obtained through MET receptor downregulation and the induction of differentiation. Cell Death Dis. 2013;4:e459 pubmed publisher
Duong V, Jaglal M, Zhang L, Kale V, Lancet J, Komrokji R, et al. Phase II pilot study of oral dasatinib in patients with higher-risk myelodysplastic syndrome (MDS) who failed conventional therapy. Leuk Res. 2013;37:300-4 pubmed publisher
O Reilly L, Zhang X, Smithgall T. Individual Src-family tyrosine kinases direct the degradation or protection of the clock protein Timeless via differential ubiquitylation. Cell Signal. 2013;25:860-6 pubmed publisher
Cipolla L, Consonni A, Guidetti G, Canobbio I, Okigaki M, Falasca M, et al. The proline-rich tyrosine kinase Pyk2 regulates platelet integrin ?IIb?3 outside-in signaling. J Thromb Haemost. 2013;11:345-56 pubmed publisher
Wheeler S, Morariu E, Bednash J, Otte C, Seethala R, Chiosea S, et al. Lyn kinase mediates cell motility and tumor growth in EGFRvIII-expressing head and neck cancer. Clin Cancer Res. 2012;18:2850-60 pubmed publisher
Alvarez D, Agaisse H. Casein kinase 2 regulates vaccinia virus actin tail formation. Virology. 2012;423:143-51 pubmed publisher
Mital J, Miller N, Fischer E, Hackstadt T. Specific chlamydial inclusion membrane proteins associate with active Src family kinases in microdomains that interact with the host microtubule network. Cell Microbiol. 2010;12:1235-49 pubmed publisher
Sirvent A, Benistant C, Pannequin J, Veracini L, Simon V, Bourgaux J, et al. Src family tyrosine kinases-driven colon cancer cell invasion is induced by Csk membrane delocalization. Oncogene. 2010;29:1303-15 pubmed publisher
Koreckij T, Nguyen H, Brown L, Yu E, Vessella R, Corey E. Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis. Br J Cancer. 2009;101:263-8 pubmed publisher
Toi S, Shibata N, Sawada T, Kobayashi M, Uchiyama S. Activation of the non-receptor tyrosine kinase cSrc in macrophage-rich atherosclerotic plaques of human carotid arteries. Acta Histochem Cytochem. 2007;40:153-61 pubmed publisher
product information
Catalog Number :
05-677
Subcategory :
Cell Signaling
Product Name :
Anti-phospho-Src (Tyr416) Antibody, clone 9A6
Product Type :
Antibodies
Clonality :
Monoclonal Antibody
Gene ID :
P12931
Host Name :
Mouse
Antigen :
phospho-Src (Tyr416)
Clone :
clone 9A6
Conjugate :
Purified
Isotype :
IgG3
Product Description :
Anti-phospho-Src (Tyr416) Antibody, clone 9A6
Cross Reactivity :
Human;Mouse
Background :
Src (also known as pp60src) is a non receptor Tyrosine Kinase involved in signal transduction in many biological systems and implicated in the development of human tumors. There are two critical phosphorylation sites of tyrosine on Src, tyrosine 418 and tyrosine 529 (referring to human Src sequence). The tyrosine 418 is located in the catalytic domain and is one of the autophosphorylation sites. Full catalytic activity of Src requires phosphorylation of tyrosine 418. This region of Src is also highly conserved in all of the related Src-family kinases, and thus prior immunoprecipitation may be required to identify which Src family member is being activated.
ALT Names :
proto-oncogene tyrosine-protein kinase SRC;protooncogene SRC, Rous sarcoma;tyrosine kinase pp60c-src;tyrosine-protein kinase SRC-1;v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog;v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)
Immunogen :
KLH-conjugated, synthetic peptide containing phosphotyrosine in the sequence context corresponding to tyrosine 416 of avian Src. Clone 9A6.
Specificity :
Recognizes phospho-Src, Mr 60kDa. The antibody does not crossreact with the nonphosphorylated form of Src or with unrelated phosphorylation sites. Predicted to recognize all Src family members phosphorylated at the tyrosine corresponding to Tyr416 of avian Src.
Package Size :
100 μg
Uses :
Western Blotting;Immunoprecipitation
Storage :
Stable for 1 year at from date of receipt.
company information
EMD Millipore
290 Concord Road
Billerica, Massachusetts 01821
bioscienceshelp@emdchemical.com
https://www.emdmillipore.com
888-854-3417
headquarters: United States
EMD Millipore is the Life Science division of Merck KGaA of Darmstadt, Germany

Hundreds of New Antibodies in the areas of:
  • • Cancer
  • • Nuclear Signaling
  • • Apoptosis
  • • Cardiovascular Disease
  • • Developmental Biology
  • • Metabolic Disease
  • • Neurodegenerative Disease
  • • Cell Biology
View all the new antibodies at www.emdmillipore.com.